Cargando…

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention

BACKGROUND: In contrast to studies of depression and psychosis, the first part of this study showed no major differences in serum levels of cytokines and tryptophan metabolites between healthy children and those with attention-deficit/hyperactivity disorder of the combined type (ADHD). Yet, small de...

Descripción completa

Detalles Bibliográficos
Autores principales: Oades, Robert D, Myint, Aye-Mu, Dauvermann, Maria R, Schimmelmann, Benno G, Schwarz, Markus J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900218/
https://www.ncbi.nlm.nih.gov/pubmed/20534153
http://dx.doi.org/10.1186/1744-9081-6-32
_version_ 1782183604068024320
author Oades, Robert D
Myint, Aye-Mu
Dauvermann, Maria R
Schimmelmann, Benno G
Schwarz, Markus J
author_facet Oades, Robert D
Myint, Aye-Mu
Dauvermann, Maria R
Schimmelmann, Benno G
Schwarz, Markus J
author_sort Oades, Robert D
collection PubMed
description BACKGROUND: In contrast to studies of depression and psychosis, the first part of this study showed no major differences in serum levels of cytokines and tryptophan metabolites between healthy children and those with attention-deficit/hyperactivity disorder of the combined type (ADHD). Yet, small decreases of potentially toxic kynurenine metabolites and increases of cytokines were evident in subgroups. Therefore we examined predictions of biochemical associations with the major symptom clusters, measures of attention and response variability. METHODS: We explored systematically associations of 8 cytokines (indicators of pro/anti-inflammatory function) and 5 tryptophan metabolites with symptom ratings (e.g. anxiety, opposition, inattention) and continuous performance test (CPT) measures (e.g. movement, response time (RT), variability) in 35 ADHD (14 on medication) and 21 control children. Predictions from linear regressions (controlled by the false discovery rate) confirmed or disconfirmed partial correlations accounting for age, body mass and socio-economic status. RESULTS: (1) Total symptom ratings were associated with increases of the interleukins IL-16 and IL-13, where relations of IL-16 (along with decreased S100B) with hyperactivity, and IL-13 with inattention were notable. Opposition ratings were predicted by increased IL-2 in ADHD and IL-6 in control children. (2) In the CPT, IL-16 related to motor measures and errors of commission, while IL-13 was associated with errors of omission. Increased RT variability related to lower TNF-α, but to higher IFN-γ levels. (3) Tryptophan metabolites were not significantly related to symptoms. But increased tryptophan predicted errors of omission, its breakdown predicted errors of commission and kynurenine levels related to faster RTs. CONCLUSIONS: Many associations were found across diagnostic groups even though they were more marked in one group. This confirms the quantitative trait nature of these features. Conceptually the relationships of the pro- and antiinflammatory cytokines distinguished between behaviours associated more with cognitive or more with motor control respectively. Further study should extend the number of immunological and metabolic markers to confirm or refute the trends reported here and examine their stability from childhood to adolescence in a longitudinal design.
format Text
id pubmed-2900218
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29002182010-07-09 Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention Oades, Robert D Myint, Aye-Mu Dauvermann, Maria R Schimmelmann, Benno G Schwarz, Markus J Behav Brain Funct Research BACKGROUND: In contrast to studies of depression and psychosis, the first part of this study showed no major differences in serum levels of cytokines and tryptophan metabolites between healthy children and those with attention-deficit/hyperactivity disorder of the combined type (ADHD). Yet, small decreases of potentially toxic kynurenine metabolites and increases of cytokines were evident in subgroups. Therefore we examined predictions of biochemical associations with the major symptom clusters, measures of attention and response variability. METHODS: We explored systematically associations of 8 cytokines (indicators of pro/anti-inflammatory function) and 5 tryptophan metabolites with symptom ratings (e.g. anxiety, opposition, inattention) and continuous performance test (CPT) measures (e.g. movement, response time (RT), variability) in 35 ADHD (14 on medication) and 21 control children. Predictions from linear regressions (controlled by the false discovery rate) confirmed or disconfirmed partial correlations accounting for age, body mass and socio-economic status. RESULTS: (1) Total symptom ratings were associated with increases of the interleukins IL-16 and IL-13, where relations of IL-16 (along with decreased S100B) with hyperactivity, and IL-13 with inattention were notable. Opposition ratings were predicted by increased IL-2 in ADHD and IL-6 in control children. (2) In the CPT, IL-16 related to motor measures and errors of commission, while IL-13 was associated with errors of omission. Increased RT variability related to lower TNF-α, but to higher IFN-γ levels. (3) Tryptophan metabolites were not significantly related to symptoms. But increased tryptophan predicted errors of omission, its breakdown predicted errors of commission and kynurenine levels related to faster RTs. CONCLUSIONS: Many associations were found across diagnostic groups even though they were more marked in one group. This confirms the quantitative trait nature of these features. Conceptually the relationships of the pro- and antiinflammatory cytokines distinguished between behaviours associated more with cognitive or more with motor control respectively. Further study should extend the number of immunological and metabolic markers to confirm or refute the trends reported here and examine their stability from childhood to adolescence in a longitudinal design. BioMed Central 2010-06-09 /pmc/articles/PMC2900218/ /pubmed/20534153 http://dx.doi.org/10.1186/1744-9081-6-32 Text en Copyright ©2010 Oades et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Oades, Robert D
Myint, Aye-Mu
Dauvermann, Maria R
Schimmelmann, Benno G
Schwarz, Markus J
Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title_full Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title_fullStr Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title_full_unstemmed Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title_short Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
title_sort attention-deficit hyperactivity disorder (adhd) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900218/
https://www.ncbi.nlm.nih.gov/pubmed/20534153
http://dx.doi.org/10.1186/1744-9081-6-32
work_keys_str_mv AT oadesrobertd attentiondeficithyperactivitydisorderadhdandglialintegrityanexplorationofassociationsofcytokinesandkynureninemetaboliteswithsymptomsandattention
AT myintayemu attentiondeficithyperactivitydisorderadhdandglialintegrityanexplorationofassociationsofcytokinesandkynureninemetaboliteswithsymptomsandattention
AT dauvermannmariar attentiondeficithyperactivitydisorderadhdandglialintegrityanexplorationofassociationsofcytokinesandkynureninemetaboliteswithsymptomsandattention
AT schimmelmannbennog attentiondeficithyperactivitydisorderadhdandglialintegrityanexplorationofassociationsofcytokinesandkynureninemetaboliteswithsymptomsandattention
AT schwarzmarkusj attentiondeficithyperactivitydisorderadhdandglialintegrityanexplorationofassociationsofcytokinesandkynureninemetaboliteswithsymptomsandattention